The Impact of ICH Q5A R2 on the Biopharmaceutical Market

BPI Contributor

February 14, 2024

fiddler-ruppach.PNG

Horst Rupach, Executive Director, Scientific and Portfolio Global Biologics, Charles River Laboratories, spoke with Brandy Fidler from Informa Connect Life Sciences about ICH Q5A R2. Rupach will be giving a presentation at BPI West in San Diego in March 2024.

Read the eBook and watch the pre-event interview here.

You May Also Like